KomiPharm, Foreigners Net Sell 4,641 Shares... Stock Price -1.35%
As of 10:32 AM on the 17th, Komipharm is trading at 18,250 KRW, down 1.35% from the previous day. This represents an 11.28% increase compared to June 15. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners are tentatively recorded as net sellers of 4,641 shares. Over the past five days, individual investors have net sold 217,281 shares, while foreigners and institutions have net bought 202,907 shares and 25,325 shares, respectively.
On June 8, Komipharm was a market issue due to the "Korean Ministry of Food and Drug Safety's rejection of the COVID-19 treatment clinical trial," which caused a weak trend.
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Hancom Breaks Away from Its 36-Year Mission and Formula for Success" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
